SARS-CoV-2 Lambda variant

Variant of SARS-CoV-2 From Wikipedia, the free encyclopedia

SARS-CoV-2 Lambda variant

The Lambda variant, also known as lineage C.37, is a variant of SARS-CoV-2, the virus that causes COVID-19.[1] It was first detected in Peru in August 2020.[2] On 14 June 2021, the World Health Organization (WHO) named it Lambda variant[1] and designated it as a variant of interest.[3] On 16 March 2022, the WHO has de-escalated the Lambda variant to "previously circulating variants of concern".[4][5]

It has spread to at least 30 countries[6] around the world and is known to be more resistant to neutralizing antibodies compared to other strains.[7][8][9] There is evidence that suggests the Lambda variant is both more infectious and resistant to vaccines than the Alpha and/or Gamma variant.[10][11]

Mutations

The Lambda genome has the following amino acid mutations, all of which are in the virus's spike protein code: G75V, T76I, Δ246-252, L452Q, F490S, D614G and T859N.[12]

History

Summarize
Perspective

First samples of the Lambda variant were detected in Peru in August 2020[2] and by April 2021, over eighty percent of new cases of COVID-19 in Peru were from the new variant.[1][14] In mid-June 2021, 90.6% of new COVID-19 cases in Arequipa and 78.1% of new cases in Cusco were the Lambda variant, according to the Peruvian Ministry of Health.[15] By this time the Lambda variant had also spread throughout South America and was detected in twenty-nine countries in total, especially in Argentina, Chile and Ecuador.[14][16] The WHO designated the Lambda variant as a "variant of interest" on 14 June 2021.[1]

On 6 July 2021, Australia reported its first case of the Lambda variant in an overseas traveler who had been in a New South Wales quarantine hotel in April.[17]

On 19 July 2021, Texas reported its first case of the Lambda variant.[18] On 22 July 2021, Florida reported 126 cumulative confirmed cases of the Lambda variant.[19] On 28 July 2021, University of Miami researchers announced random sampling showed 3 percent of COVID-19 patients in Jackson Memorial Health System and at University of Miami's UHealth Tower were infected with it.[20] On 5 August 2021, Louisiana reported its first case of the Lambda variant.[21]

On 7 August 2021, Japan confirmed its first case of the Lambda variant, with the infected person arriving in Japan from Peru on 20 July.[22]

On 15 August 2021, the Philippines confirmed its first case of the Lambda variant.[23]

Statistics

More information Country, Confirmed cases ...
Cases by country (Updated as of 23 August 2021) GISAID[24]
Country Confirmed cases Collection date
 Chile 1,489 13 July 2021
 Peru 1,480 15 June 2021
 United States 848 5 August 2021
 Ecuador 194 20 July 2021
 Mexico 189 14 July 2021
 Spain 124 7 July 2021
 Argentina 111 24 June 2021
 Germany 87 13 July 2021
 France 56 19 July 2021
 Colombia 51 29 June 2021
 Israel 25 9 May 2021
  Switzerland 8 25 July 2021
 Canada 26 21 June 2021
 The Netherlands 3 11 July 2021
 Saint Kitts and Nevis 10 6 June 2021
 Belgium 2 23 July 2021
 United Kingdom 8 10 July 2021
 Italy 12 26 June 2021
 Brazil 7 21 June 2021
 India 6 12 April 2021
 Denmark 1 11 August 2021
 Sweden 1 15 July 2021
 South Africa 3 14 July 2021
 Portugal 1 10 June 2021
 Qatar 3 13 April 2021
 Latvia 2 30 April 2021
 Aruba 2 2 June 2021
 Bolivia 1 2 June 2021
 Uruguay 1 15 April 2021
 Australia 1 3 April 2021
 Lithuania 1 19 May 2021
 Norway 1 7 July 2021
 Estonia 1 1 April 2021
 Russia 1 21 March 2021
 Finland 1 31 May 2021
 Turkey 1 8 February 2021
 Bangladesh 1 20 March 2021
 Japan 1 7 August 2021
 Philippines 1 15 August 2021[25]
 Venezuela 2 5 May 2021
 Mayotte 1 15 July 2021
 El Salvador 3 30 April 2021
 Guatemala 1 3 July 2021
 Costa Rica 4 20 July 2021
 World (44 countries) Total: 4,763 Total as of 23 August 2021
Close

See also

References

Loading related searches...

Wikiwand - on

Seamless Wikipedia browsing. On steroids.